Shingrix vaccine study reveals how immune cells protect skin in older adults
NCT ID NCT04403139
First seen May 06, 2026 · Last updated Jun 17, 2026 · Updated 9 times
Summary
This study looks at how the Shingrix vaccine, which prevents shingles, changes immune cells in the skin and blood. Researchers will compare two groups: adults aged 30-40 and those 70 or older. The goal is to understand how the vaccine creates long-lasting protection, especially in older people.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA ZOSTER VIRUS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Washington Virology Research Clinic
Seattle, Washington, 98104, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.